Sponsors / Exhibits


The organisers gratefully acknowledge sponsorship of this meeting by the following:

Alere has a long-standing heritage in Women's Health - we developed the first rapid pregnancy test, ClearBlue, and the first rapid ovulation predictor, ClearPlan. We continue to be recognised as innovators in our field and have recently introduced the Alere Triage PIGF test, for the measurement of Placental Growth Factor in maternal circulation, as an aid in the diagnosis of pre-eclampsia. At Alere, we believe in connecting you to the smartest diagnostic tools available for pre-eclampsia, preterm labour, and premature rupture of membranes, to help you place the right women onto the right clinical pathway.
Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic and medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic's core business units are focused on mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for mennorrhagia, osteoporosis assessment, and preterm birth screening.
Medaphor Scantrainer is a virtual-reality, 'real-feel' ultrasound training simulator which provides curriculum-based training and professional development, independent of a clinical setting. Structure simulator training dramatically increases trainees scanning skills prior to patient contact, removing the need to practice on live patients, and mimimising tutor teaching time in the early learning phase.
Sands, the stillbirth and neonatal death charity, was founded in 1978 and supports anyone affected by the death of a baby. We also promote and fund research to understand and prevent the loss of babies' lives. Our core aims are to:
  • offer a wide range of support services for anyone affected by the death of a baby
  • work in partnership with health professionals to try to ensure the best possible care for bereaved parents and families
  • raise awareness of stillbirth and neonatal death through public campaigns
  • promote changes in practice which could save babies' lives, and identify and fund research to further our understanding of perinatal mortality.